Skip to main content

The Treatment of Asthma — Beyond Bronchodilators

Buy Article:

$39.50 plus tax (Refund Policy)

I have attempted to indicate the importance of Ca2+ ions in the various pathogenetic processes that contribute to the development of asthma and to show how both Ca2+ entry blockers and calmodulin-active compounds may alter the function of mediator releasing cells and smooth muscle contractility in vitro as well as their effects in various experimental animal situations and on airway function in man. It would appear that the current available cardiovascular-active Ca2+ entry blockers are not very specific with regard to either airway smooth muscle or mast cell function but their observed activities certainly warrant the search for new Ca2+ antagonists that might have greater specificity for airway smooth muscle, for example, and might facilitate therapy of asthma. There have been remarkably few studies of the effects of calmodulin-active compounds on allergic processes or in asthma. The activity of these compounds in various experimental models demands that they should be further studied with respect to their possible clinical usefulness in the management of asthma and other allergic disorders.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Data/Media
No Metrics

Document Type: Research Article

Publication date: 1985-06-01

More about this publication?
  • Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.

    The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.

    Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.

    Articles marked "F" offer free full text for personal noncommercial use only.

    The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Information for Advertisers
  • Reprint Requests
  • www.AJRA.com
  • www.AllergyandRhinology.com
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more